DRUG · Mapped RxNorm record
tesamorelin
Normalized identity: tesamorelinView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Effects of Growth Hormone Releasing Hormone in HIV
NCT01263717
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEffects of Growth Hormone Releasing Hormone in HIV
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
HIVunresolved
HIV Lipodystrophyunresolved
Interventions
tesamorelinDRUG · verified · RxNorm: tesamorelin
placeboDRUG
Sponsors & collaborators
Massachusetts General Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01263717 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.